- Home
- CLDT vs RIGL Comparison
CLDT vs RIGL Comparison
Compare CLDT & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDT
- RIGL
- Stock Information
- Founded
- CLDT 2009
- RIGL 1996
- Country
- CLDT United States
- RIGL United States
- Employees
- CLDT N/A
- RIGL N/A
- Industry
- CLDT Real Estate Investment Trusts
- RIGL Biotechnology: Pharmaceutical Preparations
- Sector
- CLDT Real Estate
- RIGL Health Care
- Exchange
- CLDT Nasdaq
- RIGL Nasdaq
- Market Cap
- CLDT 374.7M
- RIGL 335.5M
- IPO Year
- CLDT 2010
- RIGL 2000
- Fundamental
- Price
- CLDT $7.61
- RIGL $38.85
- Analyst Decision
- CLDT Strong Buy
- RIGL Buy
- Analyst Count
- CLDT 2
- RIGL 5
- Target Price
- CLDT $10.75
- RIGL $38.20
- AVG Volume (30 Days)
- CLDT 264.3K
- RIGL 995.6K
- Earning Date
- CLDT 08-06-2025
- RIGL 08-05-2025
- Dividend Yield
- CLDT 4.72%
- RIGL N/A
- EPS Growth
- CLDT N/A
- RIGL N/A
- EPS
- CLDT 0.03
- RIGL 5.43
- Revenue
- CLDT $310,140,000.00
- RIGL $267,921,000.00
- Revenue This Year
- CLDT N/A
- RIGL $59.93
- Revenue Next Year
- CLDT $0.45
- RIGL N/A
- P/E Ratio
- CLDT $277.86
- RIGL $7.15
- Revenue Growth
- CLDT N/A
- RIGL 105.62
- 52 Week Low
- CLDT $5.83
- RIGL $12.66
- 52 Week High
- CLDT $10.00
- RIGL $43.72
- Technical
- Relative Strength Index (RSI)
- CLDT 63.27
- RIGL 68.57
- Support Level
- CLDT $7.57
- RIGL $39.00
- Resistance Level
- CLDT $7.82
- RIGL $42.08
- Average True Range (ATR)
- CLDT 0.16
- RIGL 2.32
- MACD
- CLDT 0.06
- RIGL -0.37
- Stochastic Oscillator
- CLDT 76.92
- RIGL 53.26
About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.